Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Role of Immune Checkpoints in COPD Evolution Towards Lung Cancer

NCT04654104 is registered in ClinicalTrials.gov with University of Catanzaro as lead sponsor.

NCT NCT04654104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04654104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Role of Immune Checkpoints in COPD Evolution Towards Lung Cancer
Lead sponsor
University of Catanzaro
Phase
Observational
Overall status
Unknown status
Start date
November 20, 2020
Completion date
December 10, 2023
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, copd, lung cancer, severe ards